Recent Company News

• 05:05 PM ET Nov 12, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:47 AM ET Nov 12, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 02:35 AM ET Nov 12, 2026
  

  Evotec upgraded to buy from sell at Intron Health, we're told (€3.16, 0.00)

• 09:00 AM ET Nov 05, 2026
  

  Transcript Intelligence: Evotec Q3 Earnings Guidance

• 09:00 AM ET Nov 05, 2026
  

  Transcript Intelligence: Evotec Q3 Earnings Themes

• 09:00 AM ET Nov 05, 2026
  

  Transcript Intelligence: Evotec Q3 Earnings Q&A

• 04:23 AM ET Nov 05, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:18 AM ET Nov 05, 2026
  

  Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals

• 01:40 AM ET Nov 05, 2026
  

  Evotec reports Q3 adjusted EBITDA (€1.6M) vs FactSet (€12.0M) [2 est, (€20)-(4M)]; confirms FY guidance (€2.89, 0.00)

• 01:31 AM ET Nov 05, 2026
  

  EQS-News: Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals